Cellbricks GmbH Patents

Patent portfolio assigned to Cellbricks GmbH (verified via public assignee records). Estimated patent count: 5. Berlin/Germany preclinical biotech combining synthetic biology and multimaterial stereolithography 3D-bioprinting (now Cellbricks Therapeutics). Patents confirmed assigned to Cellbricks GmbH (e.g. EP3018531A1, DE102018111751A1, WO2016075103A1, WO2019219605A1, WO2021104570A1; inventors incl. Lutz Kloke); count is an estimate of distinct families. Charite is listed as a partner; entities like Merck/Sanofi/J&J on the site are leadership ex-employers, not customers.